389

Compound name

Axitinib

Alt Name

Inlyta

Axinix

Compound Image

Axitinib.png

SMILES

CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)C=CC4=CC=CC=N4

Brutto

C₂₂H₁₈N₄OS

InChI

InChI=1S/C22H18N4OS/c1-23-22(27)18-7-2-3-8-21(18)28-16-10-11-17-19(25-26-20(17)14-16)12-9-15-6-4-5-13-24-15/h2-14H,1H3,(H,23,27)(H,25,26)/b12-9+

InChI Key

RITAVMQDGBJQJZ-FMIVXFBMSA-N

Approval Jurisdiction

2012 FDA, EMA, MHRA, TGA

Approved for clinical use

Renal Cell Carcinoma

CAS

319460-85-0

PubChem CID

6450551

Action

VEGFRs, PDGFRB, c-KIT

Approved Drug List

Commercial Vendor

Pfizer

Reference

Reference 2